This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Rong-duan Wang: Innovator in Pharmaceutical Complexes
Introduction
Rong-duan Wang is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on inclusion complexes. His research focuses on enhancing the solubility and therapeutic effects of butylphthalide, a compound with potential clinical applications.
Latest Patents
Wang holds a patent for "Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof." This invention relates to the complexation of butylphthalide with cyclodextrin or its derivatives, specifically hydroxypropyl-β-cyclodextrin. The goal is to improve the water-solubility of butylphthalide, facilitating the development of various clinical formulations such as infusions, injections, and oral medications. He has 1 patent to his name.
Career Highlights
Throughout his career, Wang has worked with prominent companies in the pharmaceutical industry. He has been associated with Shijiazhuang Pharmaceutical Group and Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work in these organizations has contributed to advancements in drug formulation and delivery systems.
Collaborations
Wang has collaborated with several professionals in his field, including Zhan-qi Niu and Kai Zhao. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical applications.
Conclusion
Rong-duan Wang's contributions to the field of pharmaceuticals through his patent on inclusion complexes demonstrate his commitment to improving drug solubility and therapeutic efficacy. His work continues to influence the development of effective clinical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile